A CLINICAL TRAIL TO STUDY THE EFFECT OFTWO DRUGS TIMIRGHNATRIFLAM GHRUTA AND TRIPHALADI GHRUTA ORAL ADMINISTRATION IN PATIENTS WITH MYOPIA

Comparative efficacy of the Timirghnatraifalam Ghruta verses Triphaladi Ghruta systemically along with Padabhyanga in the management of non-pathological myopiaâ??.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/051229

Enrollment

120

Registered

2023-04-03

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: H578- Other specified disorders of eye and adnexa Health Condition 3: H578- Other specified disorders of eye and adnexa Health Condition 4: H578- Other specified disorders of eye and adnexa Health Condition 5: H578- Other specified disorders of eye and adnexa

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: patient of age group 10 to 30 years with refreactive error myopia upto -2.75D [

Exclusion criteria

Exclusion criteria: patient having major ocular disease like corneal opacity cataract etc. patient having any other known ocular retinal pathology, squint, amblyopia etc

Design outcomes

Primary

Measure	Time frame
PARAMETER ARE VIHWALA DARSHANA ,NETRAYASA,SHIROBHITAPA,DURASHTA AVYAKTA DARSHAN ,AUTO REFRACTIVEMETER SNELLENS CHART,FUNDUS VEXAMINATIONTimepoint: 14 DAY,28 DAY,AFTER 6 MONTH	—

Secondary

Measure	Time frame
refreactive index wil be improvement upto -1D assisment will be done for the patient having UPTO -2.75 DTimepoint: refreactive index can be IMPROVEMENT to its possible extent28 days to 6 month	—

Countries

India

Contacts

Public ContactAMIT WAMANRAO CHANDANKHEDE

jnmc sawangi wardha

praveenakher@gmail.com9890845754

Outcome results